1 |
Kramer P, Wigger W, Rieger J, MatthaeiD, Scheler F. A new and simple method for treatment of overhydrated patients resistant to diuretics. Klin Wochenschr 1977; 55:1121-1122.
doi: 10.1007/BF01477940
pmid: 592681
|
2 |
Wang JD, Wang BE. The Guideline for the diagnosis of multiple organ dysfunction syndrome (MODS). Chin Crit Care Med 1995; 7:346-347.
|
3 |
Seldinger SI. Catheter replacement of the needle in percutaneous arteriography; a new technique. Acta Radiologica 1953; 39:368-376.
doi: 10.3109/00016925309136722
pmid: 13057644
|
4 |
Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13:818-829.
pmid: 3928249
|
5 |
Acharya SP, Pradhan B, Marhatta MN. Application of "the Sequential Organ Failure Assessment (SOFA) score" in predicting outcome in ICU patients with SIRS. Kathmandu Univ Med J (KUMJ) 2007; 5:475-483.
|
6 |
Robertson CM, Coopersmith CM. The systemic inflammatory response syndrome. Microbes Infect 8:1382-1389.Epub 2006 Mar 23.
doi: 10.1016/j.micinf.2005.12.016
pmid: 16679040
|
7 |
Fry DE. Sepsis, systemic inflammatory response, and multiple organ dysfunction: the mystery continues. Am Surg 2012; 78:1-8.
pmid: 22273282
|
8 |
Hukkanen RR, Liggitt HD, Murnane RD, Frevert CW. Systemic inflammatory response syndrome in nonhuman primates culminating in multiple organ failure, acute lung injury, and disseminated intravascular coagulation. Toxicol Pathol 2009; 37:799-804.
doi: 10.1177/0192623309343778
pmid: 19773593
|
9 |
Honore PM, Joannes-Boyau O, Gressens B. Blood and plasma treatments: the rationale ofhigh-volume hemofiltration. Contrib Nephrol 2007; 156:387-395.
doi: 10.1159/000102129
pmid: 17464149
|
10 |
Davenport A. Potential adverse effects of replacing high volume hemofiltration exchanges on electrolyte balance and acid-base status using the current commercially available replacement solutions in patients with acute renal failure. Int J Artif Organs 2008; 31:3-5.
doi: 10.1177/039139880803100102
pmid: 18286449
|
11 |
Hirasawa H, Sugai T, Ohtake Y, Oda S, Matsuda K, Kitamura N. Blood purification for prevention and treatment of multiple organ failure. World J Surg 1996; 20:482-486.
doi: 10.1007/s002689900076
pmid: 8662139
|
12 |
Chen L, Li JH, Jiang Y, Zhu SL, Zhang J. Effect of continuous blood purification for management of multiple organ failure with acute renal failure. Nan Fang Yi Ke Da Xue Xue Bao 2008; 28:896-897.
pmid: 18504226
|
13 |
Liu B, Pan AJ, Zhou SS, Wang H, Shao M, Zhang LL. Individualized and comprehensive therapy for severe acute pancreatitis in early stage: analysis of 110 cases. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2006; 18:169-171.
pmid: 16524512
|
14 |
Zhang J, Yuan C, Hua G, Tong R, Luo X, Ying Z. Early gut barrier dysfunction in patients with severe acute pancreatitis:attenuated by continuous blood purification treatment. Int J Artif Organs 2010; 33:706-715.
pmid: 21077043
|
15 |
Xu YD, Li YM, Xiao ZL, Liu XQ, He WQ, Zhong NS. Study of continuous blood purification in severe pneumonia patients with multiple organ failure. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2005; 17:747-751.
pmid: 16386185
|
16 |
Hoffmann JN, Faist E. Removal of mediators by continuous hemofiltration in septic patients. World J Surg 2001; 25:651-659.Epub 2001 Apr 12.
doi: 10.1007/s002680020027
pmid: 11369995
|
17 |
Cerda J, Sheinfeld G, Ronco C. Fluid overload in critically ill patients with acute kidney injury. Blood Purif 2010; 29:331-338.Epub 2010 Feb 19.
doi: 10.1159/000287776
pmid: 20173320
|
18 |
Kobayashi M. Acute blood purification for septic multiple organ failure. Nihon Rinsho 2004; 62:2308-2312.
pmid: 15597801
|
19 |
19 Ferraz N, Carlsson DO, Hong J, Larsson R, Fellström B, Nyholm L, et al. Haemocompatibility and ion exchange capability of nanocellulose polypyrrole membranes intended for blood purification. J R Soc Interface 2012 Feb 1. [Epub ahead of print]
doi: 10.1098/rsif.2020.0686
pmid: 33234061
|